Thienopyrrole compounds
US12070455B2 · kind B2 · utility
0Cited by
3References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2022 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | Sep 8, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of an autoimmune disease and/or inflammatory condition, including systemic lupus erythematosus and cutaneous lupus erythematosus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.